期刊文献+

菊粉益生素的最新研究进展 被引量:9

ADVANCES ON THE RESEARCH OF THE PREBIOTIC INULIN
下载PDF
导出
摘要 肠道菌群在人的健康和疾病中起着重要作用,与宿主具有二歧关系。大量证据表明菊粉益生素在人的肠道菌群内可选择性地发酵,引起双歧菌数量增加。动物和人体试验的大量证据显示,膳食中补充益生素菊粉,通过调节肠道菌群,可预防结肠癌、心脏病的发生和增进骨健康。这些作用机理是益生素功能食品领域未来面临的挑战。近十年来,高分辨率的生物学技术,尤其是代谢组学的出现,为阐明益生菌群调节代谢作用机理提供了有效的工具。 The human gut microbiota is increasingly recognized as playing a central role in human health and disease. We describe the concept of prebiotics, which use specific dietary carbohydrates to increase the numbers of what are seen as beneficial bacteria within the colon, in a selective manner. Specifically, the use of inulin in general, and certain of its fractions in particular as prebiotics, will be described. Prebiotic fructans constitute efficacious functional foods and there is strong evidence supporting the selectivity of their fermentation within the human gut microbiota, resulting in an increase in the relative numbers of Bifutobacterium spp. There is also considerable evidence, mainly from animal studies but also in humans, that dietary supplementation with prebiotic fructans, through modulation of the microbiota, plays a protective role in colon cancer, heart disease and bone health. However, the mechanisms by which this prebiotic microbiota modulation mediates such diverse health outcomes remain unclear. The future challenge facing the field of prebiotic functional foods will be the elucidation of these mechanisms of action. Recent high resolution bioomics technologies, especially metabonomics, provide the tools necessary to define the metabolic consequences of prebiotic microbiota modulation.
出处 《食品研究与开发》 CAS 北大核心 2009年第12期160-163,共4页 Food Research and Development
关键词 菊粉 益生素 健康 疾病 代谢组学 inulin prebiotic health disease metabonomics
  • 相关文献

参考文献18

  • 1Gibson G R, Beatty E R, Wang X, et al.Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin[J]. Gastroenterology, 1995,108(4):975-982.
  • 2Delzenne N, Cherbut C, Neyrinck A. Prebiotics: actual and potential effects in inflammatory and malignant chronic diseases[J].Current Opinion in Clinical Nutrition and Metabolic Care, 2003,6 (5):581- 586.
  • 3Tuohy K M, Rouzaud G C M, Bruck W M, et al. Modulation of the human gut microbiota towards improved health using prebiotics assessment of efficacy [J]. Current Pharmaceutical Design, 2005,11: 75-90.
  • 4Sanders M E, Tompkins T, Heimbach J T, et al. Weight of evidence needed to substantiate a health effect for probiotics and prebiotics: regulatory considerations in Canada, E.U. and U.S[J].European Journal of Nutrition, 2005,44(5)303-310.
  • 5Crittenden R G, Playne M J. Production, properties and applications of food-grade oligosaccharides[J].Trends in Food Science and Technology, 1996,7(11):353-361.
  • 6Molis C, Flourie B, Ouarne F, et al. Digestion, excretion, and energy value of fructooligosaccharides in healthy humans [J].American Journal of Clinical Nutrition, 1996, 64:324-328.
  • 7Elleg'ard L, Andersson H, Bosaeus I. Inulin and oligofructose do not influence the absorption of cholesterol, or the excretion of cholesterol, Ca, Mg, Zn, Fe or bile acids but increases energy excretion in ileostomy subjects[J].European Journal of Clinical Nutrition,1997,51 (1): 1-5.
  • 8Gibson G R, Wang X. Enrichment of bifidobacteria from human gut contents by oligofructose using continuous culture [J].FEMS Microbiology Letters, 1994,118(1-2):121-128.
  • 9Sghir A, Chow J M, Mackie R I.Continuous culture selection of bifidobacteria and lactobacilli from human faecal samples using fructooligosaccharide as selective substrate [J].Journal of Applied Microbiology, 1998,85(4):769-777.
  • 10Rycroft C E, Jones M R, Gibson G R, et al. A comparative in vitro evaluation of the fermentation properties of prebiotic oligosaccharides [J]. Journal of Applied Microbiology,2001, 91(5):878-887.

同被引文献108

引证文献9

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部